SARS-CoV-2-infected symptomatic patients often suffer from high fever and loss of appetite
which are responsible for the deficit of fluids and of protein intake. Many patients admitted to …

BACKGROUND: Thrombo-inflammation is central to COVID-19-associated coagulopathy. TF
(tissue factor), a driver of disordered coagulation and inflammation in viral infections, may be …

Convergence of the two pandemics: metabolic syndrome and COVID-19 over last two years
has posed unprecedented challenges to individuals as well as healthcare systems …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led
to an unprecedented global healthcare crisis. While SARS-CoV-2-associated COVID-19 …

Coronavirus disease 2019 (COVID-19) increases the risk of thromboembolic events,
especially in patients with severe infections requiring intensive care and cardiorespiratory …

Current understanding of determinants for COVID-19-related cardiovascular and
thromboembolic (CVE) complications primarily covers clinical aspects with limited …

Purpose The primary aim of this work was to convert the Information System for Research in
Primary Care (SIDIAP) from Catalonia, Spain, to the Observational Medical Outcomes …

COVID-19 has been associated with an increased risk for thromboembolic events, including
ischemic stroke, venous thromboembolism, and myocardial infarction. Studies have reported …

O objetivo deste trabalho foi descrever as características, a distribuição e as taxas de
mortalidade por suicídio entre crianças indígenas no Brasil, comparativamente as não …

Infection can trigger thrombotic events. After respiratory and other infections, people have a
3–6-fold increased risk of arterial thrombosis, such as myocardial infarction and ischaemic …